Cartesian Therapeutics, Inc.
Company Information
Industry
Pharmaceutical Preparations
SIC Code
2834
Entity Type
operating
SEC Category
Non-accelerated filerSmaller reporting company
State of Incorporation
DE
Business Address
7495 NEW HORIZON WAY, FREDERICK, MD, 21703
Mailing Address
7495 NEW HORIZON WAY, FREDERICK, MD, 21703
Phone
301-348-8698
Fiscal Year End
1231
EIN
000000000
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 4 Insider stock transaction report | April 6, 2026 | View on SEC |
| 4 Insider stock transaction report | April 6, 2026 | View on SEC |
| SCHEDULE 13D/A Beneficial ownership amendment | April 2, 2026 | View on SEC |
| 8-K Current report of material events | March 30, 2026 | View on SEC |
| SCHEDULE 13G Passive beneficial ownership (>5%) | March 13, 2026 | View on SEC |
| 4 Insider stock transaction report | March 13, 2026 | View on SEC |
| 10-K Annual financial report | March 9, 2026 | View on SEC |
| 8-K Current report of material events | March 9, 2026 | View on SEC |
| SCHEDULE 13G/A Passive ownership amendment | February 5, 2026 | View on SEC |
| 8-K Current report of material events | January 9, 2026 | View on SEC |
Annual Reports
10-K
March 9, 2026
- Expanded licensing agreement with Swedish Orphan Biovitrum AB (SOBI), validating technology and potentially generating future milestone payments and royalties.
- Announced positive preliminary Phase 1/2 data for its lead candidate, ABC-001, in an autoimmune condition, showing promising safety and efficacy signals.
Insider Trading
SELL
4 insiders
4 recent transactions
View Full Insider Trading Profile
Related Companies
Companies in the same industry (SIC: 2834)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.